Skip to main content

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Microbiotechnology

Volume 16 - 2025 | doi: 10.3389/fmicb.2025.1542875

Potential of newly isolated strain Pseudomonas aeruginosa MC-1/23 for the bioremediation of soil contaminated with selected non-steroidal antiinflammatory drugs (NSAIDs)

Provisionally accepted
  • 1 Medical University of Silesia, Katowice, Poland
  • 2 Łukasiewicz Research Network Institute of Industrial Organic Chemistry, Warsaw, Poland

The final, formatted version of the article will be published soon.

    The widespread usage of non-steroidal anti-inflammatory drugs (NSAIDs) has resulted in their significant accumulation in the environment, necessitating the development of effective methods for their removal. This study primarily isolated a bacterial strain capable of degrading specific NSAIDs and evaluated its potential for eliminating these drugs from contaminated soil through bioaugmentation. The objectives were achieved by assessing the degradation rates of ibuprofen (IBF), diclofenac (DCF), and naproxen (NPX) in liquid media and soil samples inoculated with a newly identified strain, Pseudomonas aeruginosa MC-1/23. In addition, the effect of natural soil microflora and abiotic conditions on the breakdown of the tested NSAIDs was examined. The findings revealed that strain MC-1/23 could metabolize these compounds in a mineral salt medium, utilizing them as carbon and energy sources, suggesting metabolic degradation. When nonsterile soil was augmented with the P. aeruginosa MC-1/23 strain, the degradation rates of the drugs significantly improved, as evidenced by reductions in t1/2DT50 values by 45.3-, 21.4-, and 45.8-fold for IBF, DCF, and NPX, respectively, compared with soil containing only natural microflora. These results confirm that the introduced strain enhances the catabolic potential of existing microflora.Thus, the strain's degradation and bioremediation capabilities offer valuable applications for remediating NSAID-contaminated soils.

    Keywords: Pseudomonas aeruginosa, NSAIDs, Ibuprofen, Diclofenac, Naproxen, bioaugmentation, soil bioremediation levels (Tran et al., 2018, Dolu and Nas, 2023). Furthermore, their use as supplementary treatments during the COVID-19 pandemic substantially increased global NSAID usage

    Received: 10 Dec 2024; Accepted: 18 Feb 2025.

    Copyright: © 2025 Klim, Żmijowska and Cycoń. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Mariusz Cycoń, Medical University of Silesia, Katowice, Poland

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more